Chiral gold(III) complexes: speciation, in vitro, and in vivo anticancer profile

被引：10

作者：

Arojojoye, Adedamola S. ^{[1
]}

Kim, Jong H. ^{[1
]}

Olelewe, Chibuzor ^{[1
]}

Parkin, Sean ^{[1
]}

Awuah, Samuel G. ^{[1
,2
,3
,4
]}

机构：

[1] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA

[2] Univ Kentucky, Ctr Pharmaceut Res & Innovat, Coll Pharm, Lexington, KY 40536 USA

[3] Univ Kentucky, Dept Pharmaceut Sci, Coll Pharm, Lexington, KY 40536 USA

[4] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA

来源：

CHEMICAL COMMUNICATIONS | 2022年 / 58卷 / 73期

关键词：

Mammals;

D O I：

10.1039/d2cc03081k

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Emerging synthetic development of chiral gold(III) complexes has prompted new opportunities in catalysis and material science with limited utility in biomedicine. Here, we demonstrate potential chemotherapeutic capability of [C<^>N]Au(III)Cl(R-DuPhos) (1-7) complexes, containing 1,2-bis[(2R,5R)-2,5-dialkylphospholano]benzene, which shows good stabilty, potent anticancer activity, and tolerability in mice.

引用

页码：10237 / 10240

页数：4

共 50 条

[21] Metabolic profile of chiral cobalt oxide nanoparticles in vitro and in vivo
Li, Si
Xu, Liwei
Lu, Meiru
Sun, Maozhong
Xu, Liguang
Hao, Changlong
Wu, Xiaoling
Xu, Chuanlai
Kuang, Hua
NANO RESEARCH, 2021, 14 (07) : 2451 - 2455
[22] Overcoming cisplatin resistance using gold(III) mimics: Anticancer activity of novel gold(III) polypyridyl complexes
Palanichamy, Kamalakannan
Sreejayan, Nair
Ontko, Allyn C.
JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 106 (01) : 32 - 42
[23] Stable Anticancer Gold(III)-Porphyrin Complexes: Effects of Porphyrin Structure
Sun, Raymond Wai-Yin
Li, Carrie Ka-Lei
Ma, Dik-Lung
Yan, Jessie Jing
Lok, Chun-Nam
Leung, Chung-Hang
Zhu, Nianyong
Che, Chi-Ming
CHEMISTRY-A EUROPEAN JOURNAL, 2010, 16 (10) : 3097 - 3113
[24] Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes
Abas, Elisa
Aguirre-Ramirez, Diego
Laguna, Mariano
Grasa, Laura
BIOMEDICINES, 2021, 9 (12)
[25] The role of tridentate ligands on the redox stability of anticancer gold (III) complexes
Delgado, Giset Y. Sanchez
Ferreira, Frederico Henrique do C.
Paschoal, Diego F. S.
Dos Santos, Helio F.
JOURNAL OF INORGANIC BIOCHEMISTRY, 2022, 236
[26] Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells
Zhang, Wen-Yao
Wang, Yang-Jie
Du, Fan
He, Miao
Gu, Yi-Ying
Bai, Lan
Yang, Lin-Lin
Liu, Yun-Jun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 178 : 401 - 416
[27] In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands
Khan, Taj-Malook
Gul, Noor Shad
Lu, Xing
Wei, Jian-Hua
Liu, Yan-Cheng
Sun, Hongbin
Liang, Hong
Orvig, Chris
Chen, Zhen-Feng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 333 - 343
[28] In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents
Garcia-Moreno, Elena
Tomas, Alejandro
Atrian-Blasco, Elena
Gascon, Sonia
Romanos, Eduardo
Jesus Rodriguez-Yoldi, Ma
Cerrada, Elena
Laguna, Mariano
DALTON TRANSACTIONS, 2016, 45 (06) : 2462 - 2475
[29] A revised understanding of the speciation of gold(<sc>iii</sc>) dithiocarbamate complexes in solution
Brown, Ryan K.
Bunyan, Joseph N.
Agrawal, Ashi
Li, Guoyu
Dautoras, Dominykas
Sarker, Jagodish C.
Keat, Terng Tor
Hicks, Thomas
Hogarth, Graeme
Pugh, David
DALTON TRANSACTIONS, 2025,
[30] Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes
Qiao-Yan Yi
Wen-Yao Zhang
Miao He
Fan Du
Xiu-Zhen Wang
Yang-Jie Wang
Yi-Ying Gu
Lan Bai
Yun-Jun Liu
JBIC Journal of Biological Inorganic Chemistry, 2019, 24 : 151 - 169

← 1 2 3 4 5 →